Comparison of the effect of tranexamic acid injection with conventional surgery in bleeding reduction in cleft palate patient surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180502002

Enrollment

100

Registered

2018-05-02

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain in children better surgical field for surgeon Tranexamic acid Antifibrinolytic cleft palate surgery

Interventions

Anti fibrinolytic drug ( Tranexamic acid) 10 mg/kg administered to patients in this group at the beginning of surgery,no antifibrinolytic drug administered in this group

Active Comparator Drug,No Intervention No treatment

administration of Tranexamic acid,no antifibrinolytic drug administered in this group

Eligibility

Sex/Gender

All

Age

3 Months to 3 Years

Inclusion criteria

Inclusion criteria: all children undergone cleft palate surgery , 3-36 month

Exclusion criteria

Exclusion criteria: dissatisfaction of parents

Design outcomes

Primary

Measure	Time frame
bleeding during surgery number of gauzes and volume of blood in suction ,pain hour pain scale ,pain hour pain scale ,surgeon satisfaction after surgey questionnaire	—

Secondary

Measure	Time frame
pain rate after surgery 1,2,6 hours after surgery questionnaire	—

Countries

Iran

Contacts

Public ContactIman Kashani

Department of anesthesiology, Mashhad university of medical sciences, Mashhad, Iran

kashanii941@mums.ac.ir+989153031189

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026